We are live on ! Find out more
BIOL

Biolase, Inc.
BIOL

Delisted

BIOL was delisted on the 18th of June, 2024.

Back to rankings

34 hedge funds and large institutions have $40.1M invested in Biolase, Inc. in 2016 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 4

10% more funds holding

Funds holding: 31 → 34 (+3)

7% more capital invested

Capital invested by funds: $37.4M → $40.1M (+$2.67M)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
34
Holders Change
+3
Holders Change %
+9.68%
% of All Funds
0.85%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
3
Increased
8
Reduced
4
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CCM
Camber Capital Management
Massachusetts
+$8.45M
2
OIM
Oracle Investment Management
Connecticut
+$633K
3
GIP
Granite Investment Partners
California
+$613K
4
Northern Trust
Northern Trust
Illinois
+$218K
5
Renaissance Technologies
Renaissance Technologies
New York
+$39.6K

Top Sellers

Rank Fund Capital Flow
1
CCM
Consonance Capital Management
New York
-$534K
2
PCMI
Princeton Capital Management Inc
New Jersey
-$59.3K
3
Vanguard Group
Vanguard Group
Pennsylvania
-$39.6K
4
Goldman Sachs
Goldman Sachs
New York
-$19.8K
Name Holding Trade Value Shares
Change 		Change in
Stake
State Street
26
State Street
Massachusetts
$26K – – –
Millennium Management
27
Millennium Management
New York
$25K +$19.8K +1 New
T. Rowe Price Associates
28
T. Rowe Price Associates
Maryland
$24K – – –
GC
29
Guggenheim Capital
Illinois
$18K – – –
Commonwealth Equity Services
30
Commonwealth Equity Services
Massachusetts
$17K – – –
BA
31
BlackRock Advisors
Delaware
$16K – – –
IA
32
IFP Advisors
Florida
$14K – – –
WS
33
Wedbush Securities
California
$14K – – –
Creative Planning
34
Creative Planning
Kansas
$10K +$19.8K +1 New
BIM
35
BlackRock Investment Management
Delaware
$9K – – –
TRCT
36
Tower Research Capital (TRC)
New York
$7K – – –
Bank of America
37
Bank of America
North Carolina
$4K – – –
LTFS
38
Ladenburg Thalmann Financial Services
Florida
$4K – – –
Royal Bank of Canada
39
Royal Bank of Canada
Ontario, Canada
$3K – – –
JFA
40
JNBA Financial Advisors
Minnesota
$2K – – –
Manulife (Manufacturers Life Insurance)
41
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$2K – – –
BC
42
Barnett & Company
Tennessee
$1K – – –
1
2

BIOL Hedge Fund Activity: Q4 2016 in Review

34 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Biolase, Inc. (BIOL) for Q4 2016, worth a combined $40.1M — up 7.1% from $37.4M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new BIOL positions and 0 closed out — a net gain of 3 holders — while 8 added to existing stakes and 4 trimmed.

The largest buyer was Camber Capital Management, opening a new position worth an estimated $8.45M. The largest seller was Consonance Capital Management, cutting an estimated $534K.

  • 34 institutional investors held Biolase, Inc. (BIOL) as of Q4 2016, up from 31 in Q3 2016.
  • Funds reported $40.1M of Biolase, Inc. stock for Q4 2016, up 7.1% quarter-over-quarter.
  • 3 funds opened new Biolase, Inc. positions in Q4 2016 and 0 closed out, a net change of +3 holders.
  • The largest Biolase, Inc. buyer in Q4 2016 was Camber Capital Management, an estimated $8.45M added.
  • The largest Biolase, Inc. seller in Q4 2016 was Consonance Capital Management, an estimated $534K sold.

Based on aggregated 13F filings for Q4 2016.